Exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) increases human hepatic stellate cell activation

Toxicology

Volumn 344-346, Issue , 2016, Pages 26-33

  Harvey, Wendy A ^a   Jurgensen, Kimberly ^a   Pu, Xinzhu ^a   Lamb, Cheri L ^a   Cornell, Kenneth A ^a   Clark, Reilly J ^a   Klocke, Carolyn ^a   Mitchell, Kristen A ^a  

^a BOISE STATE UNIVERSITY   (United States)

Author keywords

Collagen; Hepatic stellate cell; Liver; MCP 1; TCDD

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; POLYCHLORINATED DIBENZODIOXIN;

AGONISTS; CELL LINE; CELL PROLIFERATION; DRUG EFFECTS; HEPATIC STELLATE CELL; HUMAN; METABOLISM; PHYSIOLOGY;

CELL LINE; CELL PROLIFERATION; HEPATIC STELLATE CELLS; HUMANS; POLYCHLORINATED DIBENZODIOXINS; RECEPTORS, ARYL HYDROCARBON;

EID: 84957824692     PISSN: 0300483X     EISSN: 18793185     Source Type: Journal    
DOI: 10.1016/j.tox.2016.02.001     Document Type: Article

References (45)

1. Abraham K., Krowke R., Neubert D. Pharmacokinetics and biological-activity of 2,3,7,8-tetrachlorodibenzo-para-dioxin. 1. Dose-dependent tissue distribution and induction of hepatic ethoxyresorufin O-deethylase in rats following a single injection. Arch. Toxicol. 1988, 62:359-368.
2. Beaven S.W., Wroblewski K., Wang J.H., Hong C., Bensinger S., Tsukamoto H., Tontonoz P. Liver × receptor signaling is a determinant of stellate cell activation and susceptibility to fibrotic liver disease. Gastroenterology 2011, 140:1052-1062.
3. Black M.B., Budinsky R.A., Dombkowski A., Cukovic D., LeCluyse E.L., Ferguson S.S., Thomas R.S., Rowlands J.C. Cross-species comparisons of transcriptomic alterations in human and rat primary hepatocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol. Sci. 2012, 127:199-215.
4. Blaner W.S., O'Byrne S.M., Wongsiriroj N., Kluwe J., D'Ambrosio D.M., Jiang H.F., Schwabe R.F., Hillman E.M.C., Piantedosi R., Libien J. Hepatic stellate cell lipid droplets: a specialized lipid droplet for retinoid storage. Biochim. Biophys. Acta 2009, 1791:467-473.
5. Blomhoff R., Rasmussen M., Nilsson A., Norum K.R., Berg T., Blaner W.S., Kato M., Mertz J.R., Goodman D.S., Eriksson U., Peterson P.A. Hepatic retinol metabolism-distribution of retinoids, enzymes, and binding-proteins in isolated rat-liver cells. J. Biol. Chem. 1985, 260:3560-3565.
6. Chen L., Charrier A.L., Leask A., French S.W., Brigstock D.R. Ethanol-stimulated differentiated functions of human or mouse hepatic stellate cells are mediated by connective tissue growth factor. J. Hepatol. 2011, 55:399-406.
7. Czaja A.J. Hepatic inflammation and progressive liver fibrosis in chronic liver disease. World J. Gastroenterol. 2014, 20:2515-2532.
8. Dere E., Lee A.W., Burgoon L.D., Zacharewski T.R. Differences in TCDD-elicited gene expression profiles in human HepG2, mouse Hepa1c1c7 and rat H4IIE hepatoma cells. BMC Genom. 2011, 12:14.
9. Forgacs A.L., Dere E., Angrish M.M., Zacharewski T.R. Comparative analysis of temporal and dose-dependent TCDD-elicited gene expression in human, mouse, and rat primary hepatocytes. Toxicol. Sci. 2013, 133:54-66.
10. Friedman S.L. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol. Rev. 2008, 88:125-172.
11. Friedman S.L., Arthur M.J.P. Activation of cultured rat hepatic lipocytes by Kupffer cell conditioned medium. Direct enhancement of matrix synthesis and stimulation of cell proliferation via induction of platelet-derived growth factor receptors. J. Clin. Investig. 1989, 84:1780-1785.
12. Friedman S.L., Rockey D.C., McGuire R.F., Maher J.J., Boyles J.K., Yamasaki G. Isolated hepatic lipocytes and Kupffer cells from normal human liver: morphological and functional characteristics in primary culture. Hepatology 1992, 15:234-243.
13. Gentilini A., Marra F., Gentilini P., Pinzani M. Phosphatidylinositol-kinase and extracellular signal-regulated kinase mediate the chemotactic and mitogenic effects of insulin-like growth factor-in human hepatic stellate cells. J. Hepatol. 2000, 32:227-234.
14. Gohl G., Lehmkoster T., Munzel P.A., Schrenk D., Viebahn R., Bock K.W. TCDD-inducible plasminogen activator inhibitor type 2 (PAI-2) in human hepatocytes, HepG2 and monocytic U937 cells. Carcinogenesis 1996, 17:443-449.
15. Guo J., Loke J., Zheng F., Hong F., Yea S., Fukata M., Tarocchi M., Abar O.T., Huang H., Sninsky J.J., Friedman S.L. Functional linkage of cirrhosis-predictive single nucleotide polymorphisms of Toll-like receptor 4 to hepatic stellate cell responses. Hepatology 2009, 49:960-968.
16. Hakansson H., Ahlborg U.G. The effect of 2,3,7,8-tetrachlorodibenzo-para-dioxin (Tcdd) on the uptake, distribution and excretion of a single oral dose of 11,12-H-retinyl acetate and on the vitamin-status in the rat. J. Nutr. 1985, 115:759-771.
17. Hakansson H., Johansson L., Ahlborg U.G. Effects of 2,3,7,8-tetrachlorodibenzo-para-dioxin (Tcdd) on tissue-levels of vitamin-and on the distribution and excretion of the endogenous pool of vitamin-in the marginally vitamin a sufficient rat. Chemosphere 1988, 17:1781-1793.
18. Hanberg A., Kling L., Hakansson H. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on the hepatic stellate cell population in the rat. Chemosphere 1996, 32:1225-1233.
19. Hanberg A., Nilsson C.B., Trossvik C., Håkansson H. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the lymphatic absorption of a single oral dose of [3H]retinol and on the intestinal retinol esterification in the rat. J. Toxicol. Environ. Health A 1998, 55:331-344.
20. Hankinson O. The aryl-hydrocarbon receptor complex. Annu. Rev. Pharmacol. Toxicol. 1995, 35:307-340.
21. Håkansson H., Hanberg A. The distribution of [14C]-2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and its effect on the vitamin A content in parenchymal and stellate cells of rat liver. J. Nutr. 1989, 119:573-580.
22. Ishibashi H., Nakamura M., Komori A., Migita K., Shimoda S. Liver architecture, cell function, and disease. Semin. Immunopathol. 2009, 31:399-409.
23. Karlmark K.R., Weiskirchen R., Zimmermann H.W., Gasssler N., Ginhoux F., Weber C., Merad M., Luedde T., Trautwein C., Tacke F. Hepatic recruitment of the inflammatory Gr1(+) monocyte subset upon liver injury promotes hepatic fibrosis. Hepatology 2009, 50:261-274.
24. Kim S., Dere E., Burgoon L.D., Chang C.-C., Zacharewski T.R. Comparative analysis of AhR-mediated TCDD-elicited gene expression in human liver adult stem cells. Toxicol. Sci. 2009, 112:229-244.
25. Marra F. Hepatic stellate cells and the regulation of liver inflammation. J. Hepatol. 1999, 31:1120-1130.
26. Marra F., Valente A., Pinzani M., Abboud H. Cultured human liver fat-storing cells produce monocyte chemotactic protein-1. Regulation by proinflammatory cytokines. J. Clin. Investig. 1993, 92:1674-1680.
27. Marra F., Romanelli R., Giannini C., Failli P., Pastacaldi S., Arrighi M., Pinzani M., Laffi G., Montalto P., Gentilini P. Monocyte chemotactic protein-as a chemoattractant for human hepatic stellate cells. Hepatology 1999, 29:140-148.
28. Massari M.E., Murre C. Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms. Mol. Cell. Biol. 2000, 20:429-440.
29. Niu L.W., Wang X.H., Li J., Huang Y., Yang Z., Chen F.H., Ni H.C., Jin Y., Lu X.W., Cao Q. Leptin stimulates alpha 1(I) collagen expression in human hepatic stellate cells via the phosphatidylinositol 3-kinase/Akt signalling pathway. Liver Int. 2007, 27:1265-1272.
30. Pierre S., Chevallier A., Teixeira-Clerc F., Ambolet-Camoit A., Bui L.C., Bats A.S., Fournet J.C., Fernandez-Salguero P., Aggerbeck M., Lotersztajn S., Barouki R., Coumoul X. Aryl hydrocarbon receptor-dependent induction of liver fibrosis by dioxin. Toxicol. Sci. 2014, 137:114-124.
31. Porta C., Paglino C., Mosca A. Targeting PI3K/Akt/mTOR signaling in cancer. Front. Oncol. 2014, 4:64.
32. Puche J.E., Saiman Y., Friedman S.L. Hepatic stellate cells and liver fibrosis. Compr. Physiol. 2013, 3:1473-1492.
33. Reeves H.L., Friedman S.L. Activation of hepatic stellate cells-key issue in liver fibrosis. Front. Biosci. 2002, 7:d808-826.
34. Reif S., Lang A., Lindquist J.N., Yata Y., Gabele E., Scanga A., Brenner D.A., Rippe R.A. The role of focal adhesion kinase-phosphatidylinositol 3-kinase-akt signaling in hepatic stellate cell proliferation and type I collagen expression. J. Biol. Chem. 2003, 278:8083-8090.
35. Ross R., Raines E.W., Bowenpope D.F. The biology of platelet-derived growth-factor. Cell 1986, 46:155-169.
36. Senoo H., Yoshikawa K., Morii M., Miura M., Imai K., Mezaki Y. Hepatic stellate cell (vitamin A-storing cell) and its relative-past, present and future. Cell Biol. Int. 2010, 34:1247-1272.
37. Son G., Hines I.N., Lindquist J., Schrum L.W., Rippe R.A. Inhibition of phosphatidylinositol 3-kinase signaling in hepatic stellate cells blocks the progression of hepatic fibrosis. Hepatology 2009, 50:1512-1523.
38. Thunberg T., Ahlborg U.G., Hakansson H., Krantz C., Monier M. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the hepatic storage of retinol in rats with different dietary supplies of vitamin-(retinol). Arch. Toxicol. 1980, 45:273-285.
39. Vogel C.F., Nishimura N., Sciullo E., Wong P., Li W., Matsumura F. Modulation of the chemokines KC and MCP-by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice. Arch. Biochem. Biophys. 2007, 461:169-175.
40. Walisser J.A., Glover E., Pande K., Liss A.L., Bradfield C.A. Aryl hydrocarbon receptor-dependent liver development and hepatotoxicity are mediated by different cell types. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:17858-17863.
41. Wobser H., Dorn C., Weiss T.S., Amann T., Bollheimer C., Büttner R., Schölmerich J., Hellerbrand C. Lipid accumulation in hepatocytes induces fibrogenic activation of hepatic stellate cells. Cell Res. 2009, 19:996-1005.
42. Wong L., Yamasaki G., Johnson R.J., Friedman S.L. Induction of beta-platelet-derived growth-factor receptor in rat hepatic lipocytes during cellular activation in-vivo and in culture. J. Clin. Investig. 1994, 94:1563-1569.
43. Xu L., Hui A., Albanis E., Arthur M., O'Byrne S., Blaner W., Mukherjee P., Friedman S., Eng F. Human hepatic stellate cell lines, LX-and LX-2: new tools for analysis of hepatic fibrosis. Gut 2005, 54:142-151.
44. Yoshizawa K., Heatherly A., Malarkey D.E., Walker N.J., Nyska A. A critical comparison of murine pathology and epidemiological data of TCDD, PCB126, and PeCDF. Toxicol. Pathol. 2007, 35:865-879.
45. Zhang H.F., Lin X.H., Yang H., Zhou L.C., Guo Y.L., Barnett J.V., Guo Z.M. Regulation of the activity and expression of aryl hydrocarbon receptor by ethanol in mouse hepatic stellate cells. Alcohol Clin. Exp. Res. 2012, 36:1873-1881.